Indices-Pac Research Corporation’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q2
Sell
-13,250
Closed -$780K 99
2014
Q1
$780K Sell
13,250
-2,178
-14% -$122K 0.5% 71
2013
Q4
$787K Sell
15,428
-3,660
-19% -$183K 0.48% 65
2013
Q3
$961K Sell
19,088
-8,981
-32% -$470K 0.63% 50
2013
Q2
$1.38M Buy
+28,069
New +$1.53M 0.9% 30

Other funds holding LLY

Indices-Pac Research Corporation's LLY Position: Q2 2014 in Review

Indices-Pac Research Corporation sold out of Eli Lilly (LLY) in Q2 2014, closing a stake of 13,250 shares — an estimated $780K sold.

Indices-Pac Research Corporation first reported a position in LLY in Q2 2013 and held it in 4 quarters. The position peaked at $1.38M in Q2 2013. 1,028 funds tracked by Wall St. Rank hold LLY as of Q2 2014.

  • Indices-Pac Research Corporation reported no remaining Eli Lilly position as of Q2 2014 after selling out during the quarter.
  • Indices-Pac Research Corporation sold 13,250 Eli Lilly shares in Q2 2014, an estimated $780K.
  • Indices-Pac Research Corporation first reported a position in Eli Lilly in Q2 2013 and held it in 4 quarters.
  • Indices-Pac Research Corporation's Eli Lilly position peaked at $1.38M in Q2 2013.
  • 1,028 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2014.

Based on Indices-Pac Research Corporation's 13F filing for Q2 2014.